Balance Sheet Information

The following tables provide details of selected balance sheet line items as of March 31, 2012 and December 31, 2011 (in thousands):

Inventories

Property, Plant and Equipment, Net



	March 31, 2012			December 31, 2011
Land	$	19,369		$	19,355
Building	79,809			80,005
Machinery and equipment	219,786			213,729
Building improvements	64,956			60,628
Furniture and fixtures	22,270			21,790
Construction in-progress	1,199			2,789
Property, plant and equipment, at cost	407,389			398,296
Less: accumulated depreciation and amortization	(227,119		)	(222,215		)
Property, plant and equipment, net	$	180,270		$	176,081

Purchased Intangibles



	March 31, 2012					December 31, 2011
	Gross		Accumulated Amortization			Gross		Accumulated Amortization
Customer relationships	$	77,720	$	(17,447	)	$	77,326	$	(15,723	)
Developed technology	59,206		(38,855		)	59,206		(38,292		)
Trademarks	10,879		(1,631		)	10,817		(1,487		)
Trade names	7,300		(526		)	7,300		(435		)
In-process research and development	7,907		—			7,907		—
Total purchased intangibles	$	163,012	$	(58,459	)	$	162,556	$	(55,937	)

License, Manufacturing Access Fees and Other Assets, Net



	March 31, 2012			December 31, 2011
License and manufacturing access fees	$	68,488		$	67,906
Investment in Qualigen, Inc.	5,404			5,404
Investment in DiagnoCure, Inc.	5,000			5,000
Investment in Roka Bioscience, Inc.	4,705			4,705
Other assets	11,909			11,257
License, manufacturing access fees and other assets, at cost	95,506			94,272
Less: accumulated amortization	(34,260		)	(32,534		)
License, manufacturing access fees and other assets, net	$	61,246		$	61,738

Other Accrued Expenses